Kulkarni Sk

655 total citations
68 papers, 566 citations indexed

About

Kulkarni Sk is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Kulkarni Sk has authored 68 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 11 papers in Psychiatry and Mental health. Recurrent topics in Kulkarni Sk's work include Neuroscience and Neuropharmacology Research (24 papers), Pharmacological Receptor Mechanisms and Effects (13 papers) and Epilepsy research and treatment (9 papers). Kulkarni Sk is often cited by papers focused on Neuroscience and Neuropharmacology Research (24 papers), Pharmacological Receptor Mechanisms and Effects (13 papers) and Epilepsy research and treatment (9 papers). Kulkarni Sk collaborates with scholars based in India, United States and Pakistan. Kulkarni Sk's co-authors include B George, Ashish Dhir, Ipe Ninan, Anita Verma, Anil Kumar Verma, Mihir Roychoudhury, Angela Verma, Rajesh Kumar Goel, Doodipala Samba Reddy and NK Jain and has published in prestigious journals such as Journal of Psychopharmacology, Indian Journal of Pharmaceutical Sciences and Indian Journal of Pharmacology.

In The Last Decade

Kulkarni Sk

65 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kulkarni Sk India 15 237 160 86 82 80 68 566
Rameshwar Singh India 14 156 0.7× 160 1.0× 81 0.9× 56 0.7× 145 1.8× 31 630
Lissiana Magna Vasconcelos Aguiar Brazil 15 233 1.0× 149 0.9× 88 1.0× 85 1.0× 65 0.8× 26 577
Suzanne L. Hansen Denmark 12 307 1.3× 206 1.3× 55 0.6× 57 0.7× 61 0.8× 16 495
Guadalupe Garcı́a-Alcocer Mexico 11 194 0.8× 209 1.3× 79 0.9× 49 0.6× 63 0.8× 28 689
V V Petkov Bulgaria 15 254 1.1× 159 1.0× 93 1.1× 35 0.4× 20 0.3× 48 584
Laura C. Berumen Mexico 15 176 0.7× 213 1.3× 80 0.9× 46 0.6× 58 0.7× 33 770
Yuki Aoyama Japan 11 128 0.5× 241 1.5× 64 0.7× 51 0.6× 105 1.3× 15 565
Abdalla Elhwuegi Libya 8 180 0.8× 137 0.9× 90 1.0× 43 0.5× 64 0.8× 19 545
Catrin Sinner Austria 9 143 0.6× 75 0.5× 61 0.7× 45 0.5× 83 1.0× 11 451
Dinesh Y. Gawande United States 18 223 0.9× 234 1.5× 88 1.0× 45 0.5× 71 0.9× 33 732

Countries citing papers authored by Kulkarni Sk

Since Specialization
Citations

This map shows the geographic impact of Kulkarni Sk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kulkarni Sk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kulkarni Sk more than expected).

Fields of papers citing papers by Kulkarni Sk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kulkarni Sk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kulkarni Sk. The network helps show where Kulkarni Sk may publish in the future.

Co-authorship network of co-authors of Kulkarni Sk

This figure shows the co-authorship network connecting the top 25 collaborators of Kulkarni Sk. A scholar is included among the top collaborators of Kulkarni Sk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kulkarni Sk. Kulkarni Sk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sk, Kulkarni. (2010). Re-engineering pharmacology teaching and research: Can we adopt translational approach?. Indian Journal of Pharmacology. 42(5). 259–259. 1 indexed citations
2.
Sk, Kulkarni, et al.. (2008). Ascorbic acid inhibits development of tolerance and dependence to opiates in mice: Possible glutamatergic or dopaminergic modulation. Indian Journal of Pharmaceutical Sciences. 70(1). 56–56. 6 indexed citations
3.
Jain, NK, et al.. (2001). A simple technique to evaluate inflammatory pain along with anti-inflammatory studies in carrageenan-induced paw edema. Indian Journal of Pharmacology. 33(2). 114. 8 indexed citations
4.
Sk, Kulkarni & Ipe Ninan. (2001). Current concepts in cannabinoid pharmacology. Indian Journal of Pharmacology. 33(3). 170. 3 indexed citations
5.
Sk, Kulkarni, et al.. (2000). Effect of physostigmine and cisapride on morphine-induced delayed gastric transit in mice. 2 indexed citations
6.
Sk, Kulkarni & B George. (1999). Significance of long-term potentiation (LTP) in cognitive functions and epilepsy. Indian Journal of Pharmacology. 31(1). 14–22. 6 indexed citations
7.
Sk, Kulkarni, et al.. (1999). Obesity: An insight into its neurochemical basis and treatment. Indian Journal of Pharmacology. 31(6). 388. 7 indexed citations
8.
George, B, et al.. (1999). METHODS AND CONSIDERATIONS FOR EXPERIMENTAL EVALUATION OF ANTIEPILEPTIC DRUGS.. PubMed. 43(1). 25–43. 14 indexed citations
9.
Sk, Kulkarni & Doodipala Samba Reddy. (1998). Pharmacotherapy of male erectile dysfunction with sildenafil. Indian Journal of Pharmacology. 30(6). 367. 11 indexed citations
10.
Sk, Kulkarni, et al.. (1998). Antispasmodic activity of diclofenac and its combination with pitofenone and fenpiverinium on rat colon. Indian Journal of Pharmacology. 30(5). 323–325. 4 indexed citations
11.
Reddy, Doodipala Samba & Kulkarni Sk. (1998). Potential mechanisms of neurosteroid-induced attenuation of morphine tolerance and dependence. Indian Journal of Pharmacology. 30(1). 6–15. 4 indexed citations
12.
Sk, Kulkarni, et al.. (1998). Central nervous system depressant activities of melatonin in rats and mice.. PubMed. 36(3). 257–63. 33 indexed citations
13.
Sk, Kulkarni, et al.. (1992). Reversal of scopolamine- and dizocilpine- induced memory dysfunction by angiotensin converting enzyme inhibitors in rats and mice. Indian Journal of Pharmacology. 24(3). 147. 4 indexed citations
14.
Sk, Kulkarni, et al.. (1990). Effect of MK-801 and its interaction with adenosinergic agents and carbamazepine against hypoxic stress-induced convulsions and death in mice.. PubMed. 12(9). 595–600. 7 indexed citations
15.
Sk, Kulkarni. (1989). GABAB receptors and phaclofen.. PubMed. 11(2). 129–31. 1 indexed citations
16.
Sk, Kulkarni, et al.. (1988). Involvement of postsynaptic adrenergic mechanism(s) in the ATP-contractions of the rat anococcygeus muscle and the effect of extracellular Ca2+.. 291. 104–112. 1 indexed citations
17.
Sk, Kulkarni, et al.. (1987). Clonidine in alcohol withdrawal: a clinical report.. PubMed. 9(10). 697–8. 4 indexed citations
18.
Shukla, Vijay K., Garg Sk, & Kulkarni Sk. (1986). Yohimbine potentiates the anticataleptic action of clonidine against perphenazine-induced catalepsy in rats.. PubMed. 282(1). 44–9. 5 indexed citations
19.
Sk, Kulkarni, et al.. (1983). Effect of purinergic substances on rectal temperature in mice: involvement of P1-purinoceptors.. PubMed. 264(2). 180–6. 14 indexed citations
20.
Sk, Kulkarni. (1981). Actions of clonidine on convulsions and behaviour.. PubMed. 252(1). 124–32. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026